AgingResearch.NewsJoin free
Diabetes, Obesity & Metabolism

Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open-Label Trial

By Teruki Miyake, Osamu Yoshida, Shinya Furukawa, Show 11 more authorsYoichi Hiasa
Figure 1. Enrollment, randomisation and follow‐up.
Open the figure at full size
Figure 1. Enrollment, randomisation and follow‐up.Enrollment, randomisation and follow‐up.Miyake et al.
Randomised trial in 60 peopleInterventions

52 weeks, registered UMIN000045003

Paper

The paper

Teruki Miyake, Osamu Yoshida, Shinya Furukawa, Show 11 more authorsYoichi Hiasa

Ehime University Hospital; Ehime University

Diabetes, Obesity & Metabolism, 17 Aug 2026

doi.org/10.1111/dom.71233PubMed 42605535

More on GLP1R